Amidino-Containing Schiff Base Copper(II) and Iron(III) Chelates as a Thrombin Inhibitor

  • Toyota Eiko
    Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido
  • Sekizaki Haruo
    Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido
  • Takahashi Yu-u
    Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido
  • Itoh Kunihiko
    Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido
  • Tanizawa Kazutaka
    Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido

書誌事項

タイトル別名
  • Amidino Containing Schiff Base Copper 2 and Iron 3 Chelates as a Thrombin Inhibitor

この論文をさがす

抄録

Four series of Schiff base copper(II) and iron(III) chelates were synthesized from 4-formyl-3-hydroxybenzamidine or 3-formyl-4-hydroxybenzamidine and various L- or D-amino acids. Their inhibitory activities for bovine α-thrombin (abbreviated as thrombin) were determined. The most potent thrombin inhibitor in this series is copper(II) chelate (1g′) derived from 4-formyl-3-hydroxybenzamidine and D-Trp. Its Ki value, 2.7×10−8 M, is comparable to that of Argatroban (MD-805), which is a clinically used compound. The iron(III) chelates derived from 4-formyl-3-hydroxybenzamidine and hydrophobic L-amino acids (Val, Ile, Leu, Phe, Trp, Met) also exhibited higher inhibitory potency. It appears that coordination geometry composed of metal ion, amidino group, amino acid side chain is well accommodated to the thrombin active site. From the Ki values of Schiff base metal chelates for thrombin, the structure–activity relationships between the chelates and active site of thrombin were discussed.

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (70)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ